AS
Anil Satwani
About Anil Satwani
Data last updated:
Anil Satwani is a Managing Director at Symbiotec Pharmalab Limited (since 2002), Director at Knovea Pharmaceutical Private Limited (since 2020) and Director at Symbiotec Biologics Private Limited (since 2026), and holds 38 more current directorships. The companies operate in Pharma, Real Estate and Construction and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹757 Cr; the largest is Symbiotec Pharmalab Limited at ₹756 Cr (FY 2025). Earlier, Anil Satwani was a Director at Satwani Holdings (India) Private Limited (2025) and Designated Partner at Rareacre Free Hold Llp (2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Symbiotec Pharmalab Limited U24232MP2002PLC015293 | Managing Director | 20 Sep 2002 | 2002 | ₹756 Cr (FY 2025) | Active |
 Knovea Pharmaceutical Private Limited U24110MP2020PTC050978 | Director | 17 Feb 2020 | 2020 | ₹62.7 Lakh (FY 2025) | Active |
| Symbiotec Biologics Private Limited U21001MP2026PTC082197 | Director | 18 Feb 2026 | 2026 | Active | |
| Truebolt Industries Llp AAZ-5160 | Designated Partner | 17 Nov 2021 | 2021 | Active | |
| Stormfleet Industries Llp AAZ-5220 | Designated Partner | 17 Nov 2021 | 2021 | Active | |
| Solidray Industries Llp AAZ-5182 | Designated Partner | 17 Nov 2021 | 2021 | Active | |
| Grotrack Industries Llp AAZ-5153 | Designated Partner | 17 Nov 2021 | 2021 | Active | |
| Truewave Industries Llp AAZ-5141 | Designated Partner | 17 Nov 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Satwani Holdings (India) Private Limited U68100MP2025PTC079212 | Director | 22 Sep 2025 | 2025 | Active | |
| Rareacre Free Hold Llp AAU-9788 | Designated Partner | 07 Dec 2020 | 2020 | Active | |
| Spl Lifescience India Private Limited U24100MP2015PTC034447 | Director | 10 Jul 2015 | 2015 | Strike Off | |
| Symbiotec Steroids Private Limited U67120MP1997PTC012314 | Director | 18 Sep 1997 | 1997 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anil Satwani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhananjay Narendra Mungale | 00007563 | Symbiotec Pharmalab Limited | Nominee Director |
| Pramod Kasat | 00819790 | Symbiotec Pharmalab Limited | Director |
| Pratik Patel | 00780920 | Symbiotec Pharmalab Limited | Director |
| Raghavender Ramachandran | Symbiotec Pharmalab Limited | Cfo | |
| Rohit Brijmohan Mantri | 07435803 | Symbiotec Pharmalab Limited , Knovea Pharmaceutical Private Limited and 1 more | Nominee Director |
| Salil Jain | Symbiotec Pharmalab Limited | Company Secretary | |
| Sunita Kishnani | 06924681 | Symbiotec Pharmalab Limited | Director |
| Buggana Hariharnath | 00695002 | Knovea Pharmaceutical Private Limited , Symbiotec Zenfold Private Limited | Nominee Director |
| Kashish Satwani | 00041501 | Truebolt Industries Llp , Stormfleet Industries Llp and 33 more | Designated Partner |
| Ramesh Baheti | 00008202 | Sti Niollo Commercials Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Satwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Satwani
Anil Satwani currently holds 41 directorships: Symbiotec Pharmalab Limited (Managing Director, since 20 Sep 2002, revenue ₹756 Cr (FY 2025)); Knovea Pharmaceutical Private Limited (Director, since 17 Feb 2020, revenue ₹62.7 Lakh (FY 2025)); Symbiotec Biologics Private Limited (Director, since 18 Feb 2026); Truebolt Industries Llp (Designated Partner, since 17 Nov 2021); Stormfleet Industries Llp (Designated Partner, since 17 Nov 2021); and 36 more.
Anil Satwani was first appointed on 18 Sep 1997 as Director at Symbiotec Steroids Private Limited. The most recent appointment on record is 18 Feb 2026 at Symbiotec Biologics Private Limited.
The 2 current companies of Anil Satwani that report revenue have a combined latest revenue of ₹757 Cr: Symbiotec Pharmalab Limited ₹756 Cr (FY 2025); Knovea Pharmaceutical Private Limited ₹62.7 Lakh (FY 2025).
Anil Satwani held 4 earlier board appointments: Satwani Holdings (India) Private Limited (Director, 22 Sep 2025 to 10 Dec 2025); Rareacre Free Hold Llp (Designated Partner, 07 Dec 2020 to 29 Dec 2020); Spl Lifescience India Private Limited (Director, from 10 Jul 2015); Symbiotec Steroids Private Limited (Director, from 18 Sep 1997).
The current boards of Anil Satwani's companies include Dhananjay Narendra Mungale (Symbiotec Pharmalab Limited), Pramod Kasat (Symbiotec Pharmalab Limited), Pratik Patel (Symbiotec Pharmalab Limited), Raghavender Ramachandran (Symbiotec Pharmalab Limited), Rohit Brijmohan Mantri (Symbiotec Pharmalab Limited), Salil Jain (Symbiotec Pharmalab Limited), among others.